ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Characteristics and prognosis according to tumor location in esophageal squamous cell carcinoma.
Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to analyze location-specific characteristics and prognosis of esophageal squamous cell carcinoma (ESCC).
methodsMedical records of patients with ESCC between December 2008 and December 2024 at Pusan National University Yangsan Hospital were retrospectively reviewed. A total of 497 patients with ESCC were included in the study and classified into three groups based on tumor location: upper esophagus (n = 107), middle esophagus (n = 224), and lower esophagus (n = 166). The clinical characteristics at diagnosis and prognosis were compared among these groups.
resultsPatients with upper esophageal cancer were the oldest at the time of diagnosis (median age 70 years, p = 0.041) and were more frequently diagnosed at an advanced stage (T4 stage: 12.1%, p = 0.006). Patients with middle ESCC were diagnosed at the earliest stage (T1 stage: 48.7%, p < 0.001). Patients with lower ESCC had the highest incidence of distant metastasis at diagnosis (22.3%, p = 0.012). Overall survival was significantly lower in patients with upper ESCC (hazard ratio [HR], 1.94; 95% confidence interval [CI], 1.41-2.67; p < 0.001) and lower ESCC (HR, 1.59; 95% CI, 1.18-2.13; p = 0.002) compared to those with middle ESCC.
conclusionsEndoscopists should be particularly vigilant to avoid missing upper ESCC, and careful consideration should be given to the potential for distant metastasis in lower ESCC.
Indexed as
Identifiers
41739399What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.